EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 69 filers reported holding EVELO BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $55,000 | -84.4% | 26,116 | -74.9% | 0.00% | -100.0% |
| Q1 2022 | $352,000 | +334.6% | 103,926 | +679.6% | 0.00% | – |
| Q4 2021 | $81,000 | -31.4% | 13,330 | -20.2% | 0.00% | – |
| Q3 2021 | $118,000 | -89.7% | 16,700 | -80.0% | 0.00% | -100.0% |
| Q2 2021 | $1,147,000 | -22.1% | 83,494 | -39.4% | 0.00% | -25.0% |
| Q1 2021 | $1,473,000 | – | 137,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 18,233,403 | $145,867,000 | 5.52% |
| HARBOURVEST PARTNERS LLC | 1,763,505 | $14,108,000 | 4.99% |
| Samsara BioCapital, LLC | 227,529 | $1,820,000 | 1.43% |
| SECTORAL ASSET MANAGEMENT INC | 651,077 | $5,209,000 | 0.63% |
| Alphabet Inc. | 1,060,495 | $8,484,000 | 0.44% |
| Larson Financial Group LLC | 7,268 | $58,000 | 0.05% |
| CREDIT SUISSE AG/ | 1,103,763 | $8,830,000 | 0.01% |
| FMR LLC | 3,325,107 | $26,601,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 87,370 | $699,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,750 | $38,000 | 0.00% |